Phio Pharmaceuticals Share Price (NASDAQ: PHIO)

$2.04

▲

0.01

(0.49%)

Live

Last updated on August 22, 2025 at 12:38 AM IST

$₹

Check the interactive Phio Pharmaceuticals Stock chart to analyse performance

Phio Pharmaceuticals stock performance

as on August 22, 2025 at 12:38 AM IST

Today's Low:$2.01
Today's High:$2.09
$2.04
1.47%
Downside
Day's Volatility :3.83%
Upside
2.39%
52 Weeks Low:$0.97
52 Weeks High:$9.79
$2.04
52.66%
Downside
52 Weeks Volatility :90.14%
Upside
79.16%

Phio Pharmaceuticals Stock Returns

Period	Phio Pharmaceuticals Corp	Index (Russel 2000)
3 Months	9.78%	0.0%
6 Months	17.44%	0.0%
1 Year	-34.42%	0.0%
3 Years	-76.02%	-9.6%

Phio Pharmaceuticals Corp Key Stats

Check Phio Pharmaceuticals key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$2.03
Open	$1.99
Today's High	$2.09
Today's Low	$2.01
Market Capitalization	$9.6M
Today's Volume	$136.8K
52 Week High	$9.79
52 Week Low	$0.9657
Revenue TTM	$0.0
EBITDA	$-7.4M
Earnings Per Share (EPS)	$-2.09
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-102.18%

Stock Returns calculator for Phio Pharmaceuticals Stock including INR - Dollar returns

The Phio Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Phio Pharmaceuticals investment value today

Current value as on today

₹70,161

Returns

₹29,839

(-29.84%)

Returns from Phio Pharmaceuticals Stock

₹33,766 (-33.77%)

Dollar Returns*

₹3,927 (+3.93%)

Indian investors sentiment towards Phio Pharmaceuticals Stock

353%

Period: Jul 21, 2025 to Aug 20, 2025. Change in 30 Days versus previous period

Search interest for Phio Pharmaceuticals Stock from India on INDmoney has increased by 353% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Phio Pharmaceuticals Corp

Name
Holdings %
Name
Holdings %
Vanguard Group Inc
1.01%
Geode Capital Management, LLC
0.87%
Cetera Investment Advisers
0.80%
XTX Topco Ltd
0.23%
Morgan Stanley - Brokerage Accounts
0.13%
Tower Research Capital LLC
0.05%

Analyst Recommendation on Phio Pharmaceuticals Stock

Rating

Trend

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Phio Pharmaceuticals(by analysts ranked 0 to 5 stars)

Phio Pharmaceuticals Share Price Target

What analysts predicted

Upside of 586.27%

Target:

$14.00

Current:

$2.04

Phio Pharmaceuticals share price target is $14.00, a slight Upside of 586.27% compared to current price of $2.04 as per analysts' prediction.

Phio Pharmaceuticals Stock Insights

Price Movement
In the last 7 days, PHIO stock has moved down by -7.8%
PHIO vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 64.1% return, outperforming this stock by 98.5%
PHIO vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.1% return, outperforming this stock by 188.7%

Phio Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Phio Pharmaceuticals is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Phio Pharmaceuticals Corp Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Phio Pharmaceuticals Corp	-19.84%	17.44%	-34.42%	-76.02%	-93.07%
Regeneron Pharmaceuticals, Inc.	5.39%	-15.07%	-50.13%	-3.42%	-0.61%
Beone Medicines Ltd	4.61%	26.63%	56.19%	78.75%	30.26%
Vertex Pharmaceuticals Incorporated	-16.11%	-17.89%	-18.87%	34.22%	47.47%
Alnylam Pharmaceuticals, Inc.	40.82%	82.49%	64.08%	110.21%	247.67%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Phio Pharmaceuticals Corp	0.01	NA	NA	-1.8	-1.02	-0.56	NA	2.1
Regeneron Pharmaceuticals, Inc.	14.47	14.47	1.18	39.36	0.15	0.07	0.0	287.55
Beone Medicines Ltd	NA	NA	NA	2.33	-0.05	-0.01	NA	34.32
Vertex Pharmaceuticals Incorporated	27.73	27.73	0.58	18.04	0.23	0.13	NA	67.02
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	3.92	-2.58	-0.03	NA	1.91

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Phio Pharmaceuticals Corp	Buy	$9.6M	-93.07%	0.01	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$60.8B	-0.61%	14.47	31.37%
Beone Medicines Ltd	NA	$38.5B	30.26%	NA	-3.89%
Vertex Pharmaceuticals Incorporated	Buy	$100.0B	47.47%	27.73	31.86%
Alnylam Pharmaceuticals, Inc.	Buy	$60.1B	247.67%	NA	-12.96%

About Phio Pharmaceuticals Corp

Phio Pharmaceuticals Corp., a a clinical stage biotechnology company, engages in the development of immuno-oncology therapeutics in the United States. The company is developing PH-762, an INTASYL compound in Phase 1b dose-escalating clinical trials to reduce the expression of cell death protein 1 (PD-1), a protein that inhibits T cells' ability to kill cancer cells; and PH-762 treated double positive tumor infiltrating lymphocytes, which is in Phase 1 clinical trials to treat advanced melanoma and other advanced solid tumors. It is also developing PH-894, an INTASYL compound in IND enabling studies to silence BRD4, a protein that controls gene expression in both T cells and tumor cells, effecting the immune system and the tumor. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was incorporated in 2011 and is based in Marlborough, Massachusetts.

Organization	Phio Pharmaceuticals
Employees	5
CEO	Mr. Robert J. Bitterman
Industry	Health Technology

Key Management of Phio Pharmaceuticals Corp

Name	Title
Mr. Robert J. Bitterman	President, CEO & Chairman
Ms. Lisa Carson	Principal Financial Officer, Principal Accounting Officer and VP of Finance & Administration
Ms. Linda M. Mahoney	Senior Vice President of Development

Important FAQs about investing in PHIO Stock from India :

What is Phio Pharmaceuticals share price today?

Phio Pharmaceuticals share price today is $2.04 as on August 22, 2025 at 12:38 AM IST. Phio Pharmaceuticals share today touched a day high of $2.09 and a low of $2.01.

What is the 52 week high and 52 week low for Phio Pharmaceuticals share?

Phio Pharmaceuticals share touched a 52 week high of $9.79 and a 52 week low of $0.97. Phio Pharmaceuticals stock price today i.e. August 22, 2025 at 12:38 AM IST is trending at $2.04, lower by 79.16% versus the 52 week high.

How to invest in Phio Pharmaceuticals Stock (PHIO) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Phio Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Phio Pharmaceuticals Shares that will get you 0.7353 shares as per Phio Pharmaceuticals share price of $2.04 per share as on August 22, 2025 at 12:38 AM IST.

What is the minimum amount required to buy Phio Pharmaceuticals Stock (PHIO) from India?

Indian investors can start investing in Phio Pharmaceuticals (PHIO) shares with as little as ₹87.2 or $1 (as of August 21, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹872.00 in Phio Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on August 21, 2025). Based on Phio Pharmaceuticals share’s latest price of $2.04 as on August 22, 2025 at 12:38 AM IST, you will get 4.9020 shares of Phio Pharmaceuticals. Learn more about fractional shares .

What are the returns that Phio Pharmaceuticals has given to Indian investors in the last 5 years?

Phio Pharmaceuticals stock has given -93.07% share price returns and 17.57% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?